Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Neurology
ITP
Questions discussed in this category
Would you offer TPO-RAs to a steroid-refractory chronic ITP patient with history of stroke?
Is the thrombotic risk associated with TPO-RAs only relevant to VTE or does it also apply to arterial thromboses and stroke? Can the risk be mitigated...
1 Answer available
25895
Papers discussed in this category
British journal of haematology, 2019-05
Romiplostim in adult patients with newly diagnosed or persistent immune thrombocytopenia (ITP) for up to 1 year and in those with chronic ITP for more than 1 year: a subgroup analysis of integrated data from completed romiplostim studies.
Blood Adv, 2019 Dec 10
American Society of Hematology 2019 guidelines for immune thrombocytopenia.
Related Topics in Neurology
Breast Cancer
Head and Neck Cancers
Hematologic Malignancies
Radiation Oncology
Gynecologic Oncology
Palliation
Neuro-Oncology
Gastrointestinal Cancers
Non-malignant Disease
Pediatric Hematology/Oncology